Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.020
-0.010 (-0.49%)
At close: Jan 20, 2026, 4:00 PM EST
2.050
+0.030 (1.49%)
After-hours: Jan 20, 2026, 7:51 PM EST
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $197.19 million as of January 20, 2026. Its market cap has increased by 88.16% in one year.
Market Cap
197.19M
Enterprise Value
51.19M
1-Year Change
88.16%
Ranking
Category
Stock Price
$2.02
Market Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $649.70M to $197.19M, a decrease of -69.65%. That is a compound annual growth rate of -11.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 198.20M | -0.95% |
| Dec 31, 2025 | 200.10M | 90.94% |
| Dec 31, 2024 | 104.80M | -87.33% |
| Dec 29, 2023 | 827.40M | 35.66% |
| Dec 30, 2022 | 609.90M | -66.42% |
| Dec 31, 2021 | 1.82B | -58.45% |
| Dec 31, 2020 | 4.37B | 187.69% |
| Dec 31, 2019 | 1.52B | 39.66% |
| Dec 31, 2018 | 1.09B | -15.40% |
| Dec 29, 2017 | 1.29B | 122.48% |
| Dec 30, 2016 | 577.90M | -11.05% |
| Feb 3, 2016 | 649.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 261.50B |